From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

-
Repurposing Off-Patent Drugs: Research & Regulatory Challenges
Join us for an interactive two-day workshop to discuss challenges around repurposing drugs that are already on the market but lack commercial and regulatory incentives for further research and development.
Visit us at DIA Global
DIA 2019 Global Annual Meeting in San Diego
Project Facilitate: Enhancing the Single Patient IND Process for Oncology
May 16, 2019   |   1:00 PM to 3:30 PM FDA White Oak Campus Building 31, Room 1503 - Great Room
2019 Annual Public Meeting
Annual Public Meeting Set for May 2, 2019
Collecting Data from EA Treatment for Regulatory Submissions Presentation
Executive Director June Wasser will present Collecting Data from EA Treatment for Regulatory Submissions at the Life Science Compassionate Access Summit at 4:00 pm, Monday, March 18th in Philadelphia.
2018 Innovations in Regulatory Science Awards Dinner
The Reagan-Udall Foundation for the FDA honored two longtime U.S.
Leveraging Real-World Treatment Experience from EA Protocols
See Event Highlights and Download the Meeting Report 
Expanded Access Programs and Real-World Evidence: Public Meeting
Expanded access programs, sometimes also called “compassionate use” programs, provide patients with serious or immediately life-threatening diseases or conditions access to investigational products outside of clinical tria
2024 Innovations in Regulatory Science Awards
2023 Innovations in Regulatory Science Awards